Comparing Random Allocation and Allocation by Preference to Mindfulness Practice
Launched by CANTERBURY CHRIST CHURCH UNIVERSITY · May 3, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how choosing between two types of mindfulness meditation practices—focusing on your breath or listening to sounds—affects how beneficial these practices are for people. The study will involve healthy adults living in the UK, who will be divided into three groups: one group will pick which practice they want to try, another group will be assigned a practice randomly, and the last group will listen to an audiobook instead of practicing mindfulness. Researchers want to see how these different approaches impact participants' mindfulness levels and their interest in continuing mindfulness practice.
To participate, you must be a resident of the UK and be between the ages of 65 and 74. However, you can't take part if you're already practicing mindfulness meditation more than once a week, have significant mental health issues, or think that mindfulness might cause you distress. If you join the study, you can expect to engage in either a meditation practice or listen to an audiobook, and your experiences will help researchers understand the best ways to encourage mindfulness in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -Resident in the UK
- Exclusion Criteria:
- • Currently practicing mindfulness meditation more than once per week.
- • Experiencing significant mental health problems.
- • Believe that practicing mindfulness could cause significant distress.
- • Previously practicing mindfulness has caused significant distress.
About Canterbury Christ Church University
Canterbury Christ Church University is a leading higher education institution in the UK, renowned for its commitment to research excellence and community engagement. With a strong focus on health and social care, the university undertakes a range of clinical trials aimed at advancing medical knowledge and improving patient outcomes. By leveraging interdisciplinary collaboration and state-of-the-art facilities, Canterbury Christ Church University strives to contribute valuable insights to the scientific community while fostering innovation in healthcare practices. Its dedicated team of researchers and practitioners work diligently to ensure the highest standards of ethical conduct and scientific rigor in all clinical studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tunbridge Wells, Kent, United Kingdom
Patients applied
Trial Officials
Bobbie Scott, MSc
Principal Investigator
Canterbury Christ Church University
Fergal Jones, PhD
Study Chair
Canterbury Christ Church University
Sarah Strohmaier, PhD
Study Director
Victoria University, Melbourne
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported